State Dependent Resonance in the BG-cortical Loops
2 other identifiers
interventional
10
1 country
1
Brief Summary
Neuronal activity in circuits between the basal ganglia (BG) and motor cortical areas is abnormally synchronized and rhythmic. The oscillatory activity prevails at 8-30 Hz in untreated Parkinson's Disease (PD) and its amplitude at both subthalamic and cortical levels inversely correlates with motor impairment. Moreover, these different levels in BG-cortical loops are coherent in this frequency band. The 8-30 Hz activity is suppressed by treatment following treatment with dopaminergic drugs and is partially suppressed prior to and during voluntary movements. An unanswered question is how do BG-cortical loops become so prominently engaged in this oscillatory activity? One possible explanation is that the resonance frequencies of the loops fall in the 8-30 Hz band in the untreated state, so that oscillations in this band are transmitted particularly well. So we hypothesize loop resonances in the 8-30 Hz frequency band at rest, which should be suppressed during movement and following dopaminergic therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable parkinson-disease
Started Feb 2008
Typical duration for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2008
CompletedFirst Submitted
Initial submission to the registry
February 26, 2008
CompletedFirst Posted
Study publicly available on registry
May 23, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedAugust 28, 2014
August 1, 2014
2 years
February 26, 2008
August 27, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The results are expected to bring further light into the understanding of the mechanisms underlying the propagation of pathological oscillatory activities in PD and may provide a basis for different therapeutic strategies.
1 day
Study Arms (1)
1
EXPERIMENTALA session in condition ON DOPAMINE and the other one in condition OFF DOPAMINE.
Interventions
Stimulate STN (at 0, 5, 10, 15, 20, 25, 30, 40, 70 and 130 Hz) in chronically implanted patients at rest and during simple and complex motor tasks
Eligibility Criteria
You may qualify if:
- Parkinson's disease idiopathic evolving for more than 5 years
- Electrodes of stimulation implanted in 2 nuclei under - thalamic in the service of functional and stereotaxic neurosurgery of the CHU La timone for at least 6 months
- Doped sensibility superior to 50 % (estimated by the section III of the score UPDRS)
- Efficiency of the stimulation superior to 30 % (estimated by the section III of the score UPDRS)
You may not qualify if:
- Absence of data concerning the location of electrodes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AP-HM Timone
Marseille, Bouches Du Rhone, 13005, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
jean philippe AZULAY, MD
AP-HM
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 26, 2008
First Posted
May 23, 2008
Study Start
February 1, 2008
Primary Completion
February 1, 2010
Study Completion
December 1, 2010
Last Updated
August 28, 2014
Record last verified: 2014-08